Flosonics Medical
PrivateLast Round
Debt
Mar 3, 2025
Total Funding Raised
$44.75M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Flosonics Medical operates in Healthcare & Life Sciences and is based in Sudbury, Ontario. Its latest recorded funding round was a Debt round in March 2025.
Flosonics Medical is a medical device company that develops FloPatch, a wireless, wearable Doppler ultrasound device for real-time hemodynamic assessments.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Medical Imaging, Health IoT, Sensors
Business Model
B2B
Customer Profile
Hardware + Subscription, Hardware Sales, Government Contracts
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Flosonics Medical Comparables
Compare Flosonics Medical with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Caretaker Medical | 82% | |
| Cimon Medical | 78% | |
| Pulsify Medical | 78% |
For institutional investors. Book with your work email.
Flosonics Medical Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Debt | Mar 3, 2025 | ||||
| Series C | Mar 19, 2024 | ||||
| Series B | Feb 2, 2021 | ||||
| Grant | Jan 22, 2021 | ||||
| Accelerator | Jun 19, 2019 | ||||
Seed | Jan 29, 2018 |
For institutional investors. Book with your work email.
Flosonics Medical Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| New Leaf Venture Partners | Series C |
| Arboretum Ventures | Series C, Series B |
| MedTech Innovator | Accelerator |
| MaRS Discovery District | Seed |
| Amplify Capital | Seed |
| Genesys Capital | Series B, Seed, Series C |
| Northern Ontario Angels | Seed |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 26, 2026
Monthly visitors increased 137% MoM, reaching 6.8K.
- Jul 20, 2026
Open roles increased to 66, 90% of headcount.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- signs_new_clientSep 2, 2026
On Sep 2nd '26 in United States, Flosonics Medical signs Department of Health and Human Services as a new client through a contract worth up to $70m to develop an AI algorithm for its FloPatch wearable to help clinicians detect internal bleeding after traumatic injury.
- is_developingSep 2, 2026
Under a BARDA contract announced on Sep 1st '26 in the United States, Flosonics Medical plans to develop FloPredict with BARDA to help clinicians detect internal bleeding after traumatic injury, receiving around $15m initially and up to approximately $70m if all contract options are exercised.
- is_developingSep 1, 2026
Flosonics Medical is developing FloPredict with BARDA under a development contract announced in California on Sep 1st '26; the AI algorithm applies hemodynamic analytics to FloPatch Doppler signals to help clinicians identify patients at risk from internal hemorrhage in trauma and mass casualty settings.
- partners_withSep 1, 2026
Flosonics Medical partners with ASPR to develop FloPredict, an AI algorithm that analyzes FloPatch Doppler signals to help clinicians detect internal bleeding after traumatic injury, under a contract valued at up to $70 million announced in California on Sep 1st '26.
- is_developingSep 1, 2026
Flosonics Medical is developing FloPredict with BARDA to help clinicians detect internal bleeding and identify trauma patients who may need urgent intervention, with development announced in California on Sep 1st '26.
For institutional investors. Book with your work email.
Flosonics Medical Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Flosonics Medical's valuation, stock price, and market status.
Is Flosonics Medical a public or private company?
Flosonics Medical is a private company.
What is the current stock price of Flosonics Medical?
Flosonics Medical is a private company, so its shares have no public market price. Caplight tracks Flosonics Medical's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Flosonics Medical worth (valuation)?
Valuation information for Flosonics Medical is not publicly available.
Can I buy Flosonics Medical stock?
Flosonics Medical shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Flosonics Medical's last funding round?
Flosonics Medical's most recent funding round was Debt on March 3, 2025.
Who are the main investors in Flosonics Medical?
Key investors in Flosonics Medical include New Leaf Venture Partners, Arboretum Ventures, MedTech Innovator, iGan Partners, RBCx.
Will Flosonics Medical IPO soon?
No public IPO plans have been announced for Flosonics Medical.
How can I track Flosonics Medical secondary market activity?
Caplight tracks bids, offers, and trades in Flosonics Medical's shares on secondary markets.